Angle PLC
LSE:AGL

Watchlist Manager
Angle PLC Logo
Angle PLC
LSE:AGL
Watchlist
Price: 9.35 GBX Market Closed
Market Cap: 30.2m GBX
Have any thoughts about
Angle PLC?
Write Note

Operating Margin
Angle PLC

-959.9%
Current
-1 564%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-959.9%
=
Operating Profit
-19.4m
/
Revenue
2m

Operating Margin Across Competitors

Country UK
Market Cap 30.2m GBP
Operating Margin
-960%
Country US
Market Cap 198.3B USD
Operating Margin
17%
Country US
Market Cap 189.1B USD
Operating Margin
26%
Country US
Market Cap 140.4B USD
Operating Margin
22%
Country US
Market Cap 132.3B USD
Operating Margin
18%
Country IE
Market Cap 104.2B USD
Operating Margin
19%
Country US
Market Cap 65.2B USD
Operating Margin
14%
Country DE
Market Cap 58.1B EUR
Operating Margin
12%
Country US
Market Cap 44.1B USD
Operating Margin
28%
Country CN
Market Cap 309.1B CNY
Operating Margin
36%
Country US
Market Cap 36.2B USD
Operating Margin
13%
No Stocks Found

Angle PLC
Glance View

Market Cap
30.2m GBX
Industry
Health Care

ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. The company is headquartered in Guildford, Surrey and currently employs 102 full-time employees. The company went IPO on 2004-03-17. The Company’s lead product is the Parsortix cell separation system, which captures very rare cells from the blood. This includes circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The Company’s translational research includes ovarian cancer, breast cancer, prostate cancer and small cell lung cancer.

AGL Intrinsic Value
21.81 GBX
Undervaluation 57%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-959.9%
=
Operating Profit
-19.4m
/
Revenue
2m
What is the Operating Margin of Angle PLC?

Based on Angle PLC's most recent financial statements, the company has Operating Margin of -959.9%.